Application no. and date | 14744744.5 (espacenet) (Federated) (European Patent Register), 20140714 | Patent/reg. no. and date | DK/EP 3022192, 20171011 | Publication date | 20160525 | Priority no. and date | US 201361846355 P, 20130715, US 201461977028 P, 20140408 | EP pub. no. and date |
EP 3022192 20160525 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35 4056 Basel, CH | Applicant ref. no. | SH/GP/156239 | Inventor | ADAMS, Christopher, Novartis Institutes for BioMedical Research Inc. 100 Technology Square
Cambridge, MA 02139, US, CAPPARELLI, Michael Paul, Novartis Institutes for BioMedical Research Inc. 100 Technology Square
Cambridge, MA 02139, US, EHARA, Takeru, Novartis Institutes for BioMedical Research Inc. 100 Technology Square
Cambridge, MA 02139, US, KARKI, Rajeshri Ganesh, Novartis Institutes for BioMedical Research Inc. 100 Technology Square
Cambridge, MA 02139, US, ZHANG, Chun, Novartis Institutes for BioMedical Research Inc. 100 Technology Square
Cambridge, MA 02139, US, MAINOLFI, Nello, 12 Oakley Road
Belmont, MA 02478, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/454 (2006.01) , A61K 31/4545 (2006.01) , A61K 31/5377 (2006.01) , A61P 27/00 (2006.01) , A61P 37/00 (2006.01) , C07D 401/06 (2006.01) , C07D 401/14 (2006.01) , C07D 403/06 (2006.01) , C07D 413/14 (2006.01) , C07D 417/14 (2006.01) | Title | Piperidinylindolderivater og deres anvendelse som komplement faktor B inhibitorer | Int. application no. | US2014046515 | Int. publication no. | WO2015009616 | Related patent (certificate) | CA 2024 00035 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|